US Supreme Court hears oral arguments in Mensing and Demahy pre-emption case
This article was originally published in SRA
Executive Summary
The US Supreme Court has heard oral arguments in Pliva v Mensing, Actavis v Mensing and Actavis v Demahy (Mensing and Demahy) a consolidated case in which the justices are examining whether generic drug makers have the same obligations as brand-name manufacturers to update product labelling when new risks come to light1-3.